Education, Research & Positions
A new first-line option for advanced-stage anal squamous cell carcinoma
A new first-line option for advanced-stage anal squamous cell carcinoma Summary A novel drug combination of chemotherapy (carboplatin and paclitaxel) plus the immunotherapy drug pembrolizumab has emerged as a promising new first-line treatment for advanced-stage Read More
